OmniAb, Inc. - Common Stock (OABI)

OmniAb (OABI) Q1 2026 Earnings Transcript

OmniAb (NASDAQ:OABI) reported first-quarter 2026 results that management characterized as a “very strong start to the year,” driven primarily by clinical progress across its partner portfolio and associated milestone revenue. Partner program progress drives revenue outperformance President and CEO

OmniAb (OABI) Q4 2025 Earnings Call Transcript

Shares of Ligand Pharmaceuticals are absolutely flying as investors line up behind the company's unique royalty-based model.

OABI stock results show that OmniAb beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

OABI stock results show that OmniAb missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Although U.S. stocks closed lower on Monday, there were a few notable insider trades.

OABI stock results show that OmniAb beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per share on revenue of $207.00 million.

While you can likely achieve a higher degree of success with blue chips, for blistering gains, turn to powerful small-cap stocks.